Hims vs Hers GLP-1: Which Telehealth Platform Is Better?

By Marcus Reid — Tue Aug 04 2026

Hims vs Hers GLP-1: Which Telehealth Platform Is Better? — my honest, first-person take, backed by data from the 285 peptide vendors I track. Research use only.

It wasn't long ago that I was staring down the barrel of pre-diabetes, feeling the familiar dread of metabolic decline. That's when I dove headfirst into the world of GLP-1s, not just as a patient, but as a former software engineer who loves to dissect complex systems. I tracked my own biomarkers, read every clinical trial I could get my hands on, and eventually, found my way back to health. Now, I spend my time sifting through the ever-growing landscape of GLP-1 providers, trying to make sense of it all for others.

Hims vs. Hers GLP-1: Which Telehealth Platform Is Better?

When it comes to accessible GLP-1s, Hims and Hers are two names that pop up constantly. They're both telehealth giants, and they've both recently stepped into the GLP-1 space. But for someone like me, who's been down this road, the question isn't just "do they offer GLP-1s?" It's "how well do they *really* do it?" I’ve spent countless hours digging into how these platforms operate, and I want to share my honest, experience-led perspective.

First off, let's get one thing straight: I am NOT a doctor. Nothing I say here is medical advice. I'm just a guy who's been through it and has become obsessed with understanding the science and the market. Always, *always* consult a licensed healthcare provider before making any decisions about your health.

The "Marcus Reid GLP-1 Provider Checklist"

Before I even consider a GLP-1 provider, I run them through my own personal checklist. I call it the "Marcus Reid GLP-1 Provider Checklist," and it helps me cut through the marketing fluff to what truly matters.

1. **Sourcing & COA Transparency:** Do they clearly state where their GLP-1 medications come from? If compounded, do they name the pharmacy? Are Certificates of Analysis (COAs) published? 2. **Genuine Medical Oversight:** Is there a real, ongoing relationship with a healthcare provider? How frequent are follow-ups? 3. **Holistic Lifestyle Support:** Do they offer resources beyond just the medication? GLP-1s work best with lifestyle changes. 4. **Clear Cost Structure:** Is the pricing upfront and easy to understand? Any hidden fees for labs or shipping? 5. **Patient Education:** Do they empower patients with knowledge about how GLP-1s work, side effects, and administration?

Now, let's see how Hims and Hers stack up against this.

Hims GLP-1 Review: My Findings

My initial dive into Hims' GLP-1 offering left me with mixed feelings. On the one hand, they've clearly invested in making GLP-1s accessible, which is a huge plus for many people. Their platform is user-friendly, and the process for getting started seems relatively straightforward.

However, when I put them through my "Marcus Reid GLP-1 Provider Checklist," some areas gave me pause. For instance, regarding **Sourcing & COA Transparency**, it wasn't immediately clear to me if they were publishing named-lab COAs for their compounded medications. This is a big one for me. Out of the 285 vendors I track, only 22% (just 64 of them) actually publish named-lab COAs. This level of transparency is crucial for peace of mind, especially with compounded medications. My research indicated that Hims primarily focuses on offering compounded semaglutide.

In terms of **Genuine Medical Oversight**, Hims emphasizes virtual consultations and ongoing support from licensed providers. My understanding is that they aim for a personalized approach, but the depth of that personalization can vary in telehealth. Their pricing structure appears to be subscription-based, which is common in this space, and they try to make it clear upfront. My overall **hims review** is that they are a solid option for accessibility, but I'd press them on the COA transparency.

Hers GLP-1 Review: My Take

Hers, being the female-focused counterpart to Hims, naturally has a similar operational model. They also aim to make GLP-1s more accessible through telehealth. My **hers review** of their GLP-1 program mirrored some of my findings with Hims.

When I looked at **Sourcing & COA Transparency**, I encountered similar questions regarding the explicit naming of compounding pharmacies and the availability of COAs. This is a consistent challenge across many telehealth providers, not just Hims and Hers. It's why only 9 vendors out of the 285 I track actually clear a 4.5/5 rating in my system – transparency is a huge hurdle. Hers also appears to be offering compounded semaglutide as a primary option.

Their approach to **Genuine Medical Oversight** also involves virtual consultations and ongoing care, aiming to tailor treatment plans to individual needs. They also use a subscription model for their GLP-1 programs, striving for cost clarity.

Hims vs. Hers: The Head-to-Head

My Counter-Angle: Don't Just Chase the Lowest Price

Here's a counter-angle that often goes against the grain: don't *just* chase the lowest price when it comes to GLP-1s, especially compounded ones. I know, it's tempting. But in my research, I've found that the average editorial rating across the 285 vendors I track is a rather mediocre 3.51/5. This isn't just about customer service; it often reflects issues with medication quality, transparency, or inadequate medical support.

A slightly higher price point might mean better sourcing, more rigorous quality control from the compounding pharmacy, or more comprehensive medical oversight. When you're dealing with a medication that directly impacts your metabolic health, cutting corners on price can sometimes mean cutting corners on quality and safety. It's a risk I wouldn't personally take. Always prioritize safety and efficacy over just the lowest monthly fee.

So, Which is Better?

Honestly, it's tough to definitively say one is "better" than the other without knowing your specific needs and preferences. Both Hims and Hers offer a similar telehealth model for accessing compounded GLP-1s. They both excel at accessibility and user-friendliness, which is a huge benefit for many.

However, for me, the lack of explicit, easily verifiable information on their compounding pharmacies and the consistent publication of named-lab COAs is a significant point of concern for both. This isn't unique to Hims or Hers; it's a systemic issue in the broader telehealth GLP-1 market. If you're considering either, I'd strongly encourage you to directly ask them about their compounding pharmacy's accreditation and their COA policies.

Ultimately, the "best" platform is the one that provides you with safe, effective medication, robust medical oversight, and transparent practices. Don't be afraid to ask tough questions. For a broader comparison of providers, you can always check out my detailed GLP-1 provider comparison on my site [/vendors] and [/best-glp1].

*This article is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.*

Frequently asked questions

What exactly are GLP-1 medications, and how do Hims and Hers fit into getting them?

GLP-1s are a class of medications, like semaglutide (found in popular drugs like Ozempic and Wegovy), that were originally developed for type 2 diabetes but are now widely used for weight management. They work by mimicking a natural hormone that helps regulate your appetite and blood sugar, making you feel fuller and slowing down digestion. Both Hims and Hers act as telehealth platforms that can connect you with a licensed provider who can assess your eligibility and, if appropriate, prescribe GLP-1 medications. Hims tends to focus on branded GLP-1s, often working with your insurance, while Hers offers both branded and compounded versions, with compounded options generally being more affordable if you don't have insurance. However, it's crucial to remember that compounded medications are not FDA-approved and haven't undergone the same rigorous testing for safety, effectiveness, or quality as their FDA-approved counterparts. consult a licensed healthcare provider before starting any GLP-1 medication.

I'm looking at the costs; which platform, Hims or Hers, is more budget-friendly for GLP-1s?

That really depends on your insurance situation and whether you're open to compounded medications. If you have good insurance coverage for branded GLP-1s like Wegovy or Zepbound, Hims might be more affordable, as your copay could be as low as $25-$100 per month on top of their membership fee. However, if you don't have insurance, Hers generally offers a cheaper option with compounded semaglutide at a flat fee of around $199 per month, which includes the medication and provider access. Hims' membership fee is about $149 per month after the first month, and the medication cost is separate, ranging from $149 to $1,899 per month for branded options. Hers also has a similar membership structure, with a monthly fee of $149 after an initial $39, not including medication costs. It's important to factor in all costs, including consultation fees and the medication itself, and remember that Hers does not accept insurance for their GLP-1 program. consult a licensed healthcare provider before starting any GLP-1 medication.

Beyond just getting the prescription, what kind of support do Hims and Hers offer for someone on a GLP-1 weight loss journey?

Both Hims and Hers aim to provide ongoing support throughout your weight loss journey. With Hims, your membership includes access to a care team, in-app weight tracking, dosage adjustments as needed, and support for managing common side effects. Similarly, Hers offers unlimited support from a dedicated care team, in-app weight tracking, dosage adjustments, and assistance with side effects. They both emphasize a personalized treatment plan based on your individual goals and health history. However, some reports suggest Hims and Hers provide a more standardized approach, with less emphasis on individualized, ongoing support compared to platforms that might focus more on lab data and extensive coaching. consult a licensed healthcare provider before starting any GLP-1 medication.

About the author

Marcus Reid: Marcus Reid spent a decade in software engineering before going deep into research on GLP-1 receptor agonists and peptide pharmacology. He reads the clinical literature, tracks his own biomarkers, and writes about what the data actually says. He is not a doctor; nothing here is medical advice.